Literature DB >> 35303420

Single-cell landscapes of primary glioblastomas and matched explants and cell lines show variable retention of inter- and intratumor heterogeneity.

Véronique G LeBlanc1, Diane L Trinh1, Shaghayegh Aslanpour2, Martha Hughes2, Dorothea Livingstone2, Dan Jin1, Bo Young Ahn3, Michael D Blough3, J Gregory Cairncross2, Jennifer A Chan4, John J P Kelly2, Marco A Marra5.   

Abstract

Glioblastomas (GBMs) are aggressive brain tumors characterized by extensive inter- and intratumor heterogeneity. Patient-derived models, such as organoids and explants, have recently emerged as useful models to study such heterogeneity, although the extent to which they can recapitulate GBM genomic features remains unclear. Here, we analyze bulk exome and single-cell genome and transcriptome profiles of 12 IDH wild-type GBMs, including two recurrent tumors, and of patient-derived explants (PDEs) and gliomasphere (GS) lines derived from these tumors. We find that PDEs are genetically similar to, and variably retain gene expression characteristics of, their parent tumors. Notably, PDEs appear to exhibit similar levels of transcriptional heterogeneity compared with their parent tumors, whereas GS lines tend to be enriched for cells in a more uniform transcriptional state. The approaches and datasets introduced here will provide a valuable resource to help guide experiments using GBM-derived models, especially in the context of studying cellular heterogeneity.
Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3D models; explant; glioblastoma; gliomasphere; patient-derived models; single-cell RNA-seq; single-cell genome sequencing; single-cell genomics; whole-exome sequencing

Mesh:

Year:  2022        PMID: 35303420     DOI: 10.1016/j.ccell.2022.02.016

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   38.585


  5 in total

Review 1.  Leveraging extrachromosomal DNA to fine-tune trials of targeted therapy for glioblastoma: opportunities and challenges.

Authors:  Imran Noorani; Paul S Mischel; Charles Swanton
Journal:  Nat Rev Clin Oncol       Date:  2022-09-21       Impact factor: 65.011

Review 2.  Towards precision oncology with patient-derived xenografts.

Authors:  Eugenia R Zanella; Elena Grassi; Livio Trusolino
Journal:  Nat Rev Clin Oncol       Date:  2022-09-23       Impact factor: 65.011

Review 3.  Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updated.

Authors:  Keywan Mortezaee; Jamal Majidpoor; Ebrahim Kharazinejad
Journal:  Med Oncol       Date:  2022-09-07       Impact factor: 3.738

Review 4.  Current knowledge of protein palmitoylation in gliomas.

Authors:  Feng Tang; Zhenyuan Liu; Xi Chen; Jinzhou Yang; Zefen Wang; Zhiqiang Li
Journal:  Mol Biol Rep       Date:  2022-08-31       Impact factor: 2.742

5.  Transcriptome Changes in Glioma Cells Cultivated under Conditions of Neurosphere Formation.

Authors:  Natalia S Vasileva; Elena V Kuligina; Maya A Dymova; Yulya I Savinovskaya; Nikita D Zinchenko; Alisa B Ageenko; Sergey V Mishinov; Anton S Dome; Grigory A Stepanov; Vladimir A Richter; Dmitry V Semenov
Journal:  Cells       Date:  2022-10-02       Impact factor: 7.666

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.